Roche, Horizon lead way for pharma reputation among rare disease patient groups

Roche, Horizon lead way for pharma reputation among rare disease patient groups

Source: 
Medical Marketing and Media
snippet: 

Still, the pharma industry scored lower in 2022 for key activities that are meaningful to these rare disease patient groups, including fair pricing policies and access to medicines.